LACunar Intervention Trial-2 HTML TitleLACI-2DescriptionLACunar Intervention Trial-2Assessment of safety & efficacy of cilostazol & isosorbide mononitrate to prevent recurrent lacunar stroke & progression of cerebral small vessel disease.StatusActivePIProf Joanna WardlawEdinburgh Imaging CollaboratorDr Gordon BlairDr Fergus DoubalMs Eleni SakkaDiseaseSmall Vessel Disease (SVD)Facility / resourceEIF RIEEIF WGHProject type FundingBritish Heart Foundation (BHF) Relevant links16 Jun 21. LACI-2 recruitment complete04 Dec 20. LACI-2 study resumed24 Apr 19. New Stroke Drug23 May 18. New trial for stroke - LACI-219 Apr 17. Stroke instances up by 30% Relevant Edinburgh Imaging publications21 Apr 20. Featured Paper. Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease. This article was published on 2024-08-22
HTML TitleLACI-2DescriptionLACunar Intervention Trial-2Assessment of safety & efficacy of cilostazol & isosorbide mononitrate to prevent recurrent lacunar stroke & progression of cerebral small vessel disease.StatusActivePIProf Joanna WardlawEdinburgh Imaging CollaboratorDr Gordon BlairDr Fergus DoubalMs Eleni SakkaDiseaseSmall Vessel Disease (SVD)Facility / resourceEIF RIEEIF WGHProject type FundingBritish Heart Foundation (BHF) Relevant links16 Jun 21. LACI-2 recruitment complete04 Dec 20. LACI-2 study resumed24 Apr 19. New Stroke Drug23 May 18. New trial for stroke - LACI-219 Apr 17. Stroke instances up by 30% Relevant Edinburgh Imaging publications21 Apr 20. Featured Paper. Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease.